Brief: Ryvu Therapeutics Says Its Project Recommended For Funding By Poland's PARP
27/03/2024 07:48
March 27 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* SAYS RYVU PROJECT RECOMMENDED FOR FUNDING BY POLISH AGENCY
FOR
ENTERPRISE DEVELOPMENT
* TOTAL VALUE OF PROJECT AT 39.2 MILLION ZLOTYS
* RECOMMENDED VALUE OF SUBSIDY AT 26.3 MILLION ZLOTYS
* ONCO PRIME PROJECT RELATED TO ANTICANCER THERAPY
Source text for Workspace: ID:nEM1bmJ9pa
Further company coverage: RVU.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys